Home›Articles›Avlayah for Hunter syndrome: treating the brain early, approved on an expedited pathArticleAvlayah for Hunter syndrome: treating the brain early, approved on an expedited pathArticlesConnectionsSourcesComments (0)Reader Challenges (0)ConnectionsArticle OnTividenofusp alfa, Drugs and Medicinal Substances Well-attested SourcesTividenofusp alfa (Wikipedia)Legal statusQuote, Legal statusThe FDA granted accelerated approval for Avlayah to Denali Therapeutics.View the SourceMedicine Atlas Original Articlestier 1Comments (0)No comments yet. Be the first to share a thought.Sign in to join the discussion.Reader Challenges (0)No disputes yet. Spotted an error or a better source? Open the first one.Sign in to dispute this or suggest a correction.